The Food and Drug Administration issued a warning in June 2011 that diabetic patients who have taken Actos and other pioglitazone-containing medicines are at a higher risk of developing bladder cancer. The warning notes that the risk is higher in patients who have taken higher dosages of Actos for more than 12 months.
France has stopped the release of these drugs. The FDA noted that it was aware of France’s decision. However, the FDA has not banned these medicines from being issued in the United States.
Gersowitz Libo & Korek, P.C. has been researching patients who have developed bladder cancer as a result of taking Actos and is now accepting new clients. If you or a loved one has fallen victim to the drug Actos, contact Gersowitz Libo & Korek, P.C. at (800) 529-9997 to learn your legal rights.
Investigation Underway After Police Shoot and Kill Man During Mental Health Crisis VESTAL, NEW YORK…
53-Year-Old Died in Borough Park, Brooklyn Dump Truck Collision by 16th Avenue and 49th Street…
Investigation Underway After Building Fire in the Bronx Results in Two Fatalities, Multiple Injuries BRONX,…
Investigation by N.T.S.B. Reveals Communication Failures Preceded Fatal Plane Crash With Fire Truck at LaGuardia…
Six Adults, Nine Children Injured in Queens School Bus Accident on the Long Island Expressway…
Day Care Teacher Devonte Brown Arrested After Being Accused of Molesting Young Girls at The…